Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Go back to Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 11.35 +0.70 (6.57%)
Previous Close $10.65    52 Week High $7.95 
Open $10.65    52 Week Low $0.40 
Day High $11.40    P/E N/A 
Day Low $10.41    EPS $-5.33 
Volume 677,165